Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Pain, Orthopedic, Psychiatric, Pain |
| Therapuetic Areas: | Musculoskeletal, Psychiatry / Psychology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 3/22/2019 |
| Start Date: | June 2015 |
| End Date: | June 2019 |
| Contact: | Aaron Yue, MD |
| Email: | xuanyue@stanford.edu |
| Phone: | (650) 497-0485 |
The investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of
complex regional pain syndrome (CRPS). Study participants will be randomly assigned to
receive either LDN or placebo for a period of several weeks. During this period participants
will be asked to come to several visits, which will include sensory testing, physical
assessments, and questionnaires.
complex regional pain syndrome (CRPS). Study participants will be randomly assigned to
receive either LDN or placebo for a period of several weeks. During this period participants
will be asked to come to several visits, which will include sensory testing, physical
assessments, and questionnaires.
Inclusion Criteria:
- Upper and/or lower extremity CRPS
- On stable treatment for 3 months
- CRPS for at least 1 year
- Meet the Budapest criteria for CRPS at time of the study.
Exclusion Criteria:
- Any known allergy to naltrexone or naloxone
- Use of prescription opioid analgesics or illegal opioid use
- Current of planned pregnancy.
We found this trial at
1
site
Palo Alto, California 94304
Principal Investigator: Sean Mackey, MD, PhD
Phone: 650-497-0485
Click here to add this to my saved trials
